Novo Nordisk is going to drastically reduce the price of its GLP-1 medications next year. The move could give the company's struggling growth rate a big boost. The company's high margins give it room ...

GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 20301Proprietary Forzet formulation provides ...

A person dealing with a chronic illness and rising expenses says they are doing everything they can to stay financially responsible, even as some of their friends insist that certain debts simply do ...

Recognizing this, Preferred Dental is moving toward a more diagnostic and preventative model of care that views the mouth as a mirror of the body’s internal environment. By identifying early markers ...

Regulatory expansion positions deucravacitinib 6 mg once daily as a first-in-class oral TYK2 option for active PsA, complementing its prior plaque psoriasis indication. POETYK PsA-1 showed significant ...

Shares in Roche dropped more than 5% on Monday as the Swiss drugmaker failed to show that its promising drug candidate ...

Hundreds of NHS patients are set to be removed from a privately-run mental health hospital following a string of allegations of patient abuse and neglect. On Monday, NHS England issued a letter to ...

UAB Hospital is the nation’s fifth largest hospital, according to a recent ranking of the 60 largest American medical centers ...

The companies have been embroiled in a row about compounded GLP-1 drugs that escalated to a lawsuit last month. The legal action has now been dropped and the former adversaries have struck a deal that ...

The Trump administration launched a drug pricing initiative offering immediate savings, but experts debated whether lower ...

Santa Clara County is forecasting additional stress on its public health care system — the second largest in the state — if the only rural hospital in neighboring San Benito County closes. A January ...

Intellia Therapeutics remains a 'Sell' despite the FDA lifting the clinical hold on its ATTR-CM program due to persistent commercial and safety concerns. NTLA faces a crowded competitive landscape in ...